Home / Street Sector / Stock under Wrathful Analysts Valuation: Colgate-Palmolive Co. (NYSE:CL), Polaris Industries Inc. (NYSE:PII)

Stock under Wrathful Analysts Valuation: Colgate-Palmolive Co. (NYSE:CL), Polaris Industries Inc. (NYSE:PII)

Shares of Colgate-Palmolive Co. (NYSE:CL) [Trend Analysis] swings enthusiastically in regular trading session, it a gain of 0.90% to close at $72.81. Lets us look over what analysts have to say about performance of the CL. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $0.73 as compared to the next year Q1 current trend of $0.76. While on annual basis the current EPS estimates trend for FY 2017 came in for $3.09 as compared to three months ago $3.09.

The stock prices target chart showed high target of 88 kept by analysts at WSJ while the average price target was for 76.76 as compared to current price of 72.75. Somehow, the stock managed to gain BUY ratings by 3 analysts in current tenure as 2 analysts having overweight ratings, 14 recommend as HOLD. Overall, the consensus ratings were for Hold by the pool of analysts.

Moving forward to saw long-term intention, the experts calculate Return on Investment of 25.20%. The stock is going forward its fifty-two week low with 20.61% and lagging behind from its 52-week high price with -3.40%. CL last month stock price volatility remained 1.02%.

Polaris Industries Inc. (NYSE:PII) [Trend Analysis] retains strong position in active trade, as shares scoring 0.20% to $75.60 in a active trade session, while looking at the shares volume, around 117188 shares have changed hands in this session. Finally to see some strong financial remarks by WSJ over PII performance. Out of the pool of analysts 5 gave their BUY ratings on the stock in previous month as 5 analysts having BUY in current month. The stock was ranked as Underweight by no one while 1 analyst gave SELL rank. Majority ranked Hold from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $0.46 while one month ago this estimate trend was for $0.50. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $5.28 and for the one month was for $5.49 as compared to three months ago was for $6.95. Whereas, PII received highest price target of 110 and low target of 56. The stock price target chart showed average price target of 82.11 as compared to current price of 75.44.

The firm has institutional ownership of 91.70%, while insider ownership included 0.10%. PII attains analyst recommendation of 2.70 with week’s performance of 1.58%. Investors looking further ahead will note that the Price to next year’s EPS is 46.46%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Recommended Momentum ‘How’ and ‘Why’: PPG Industries (NYSE:PPG), Allergan (NYSE:AGN)

PPG Industries, Inc. (NYSE:PPG) [Trend Analysis] try to make new thrust in street and making different …

Leave a Reply

Your email address will not be published. Required fields are marked *